ValueScreener

ValueScreener company report

Moelis & Company (MC)

NYSE / Financial Services / Financial - Capital Markets

Share price

54.55 USD Market dataClose of Oct 16, 2026

Market capitalisation

4.04B USD Market dataClose of Oct 16, 2026
Market data
Oct 16, 2026
Filed accounts
FY2025, filed Feb 26, 2026
Ratios computed
Oct 16, 2026
Filed years
13, FY2012 to FY2025
Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means
SEC filingFiled with the SEC
Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement
What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data
Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener
Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.
Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Four questions, at a glance

Quality

Return on equity

45.7% Computed

From the FY2025 filing

Read quality

Financial strength

Debt to equity

n/a Computed

From the FY2025 filing

Why n/a

The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.

Read financial strength

Valuation

Price to earnings

15.57x Computed

FY2025 accounts, priced at the latest close

Read valuation

Cash generation

Dividend yield

4.8% Computed

FY2025 accounts, priced at the latest close

Read cash generation

Revenue and net income, as filed

FY2016 Net income: 141.9M USDFY2017 Net income: 126.5M USDFY2018 Net income: 208.0M USDFY2019 Net income: 135.7M USDFY2020 Net income: 218.4M USDFY2021 Net income: 423.0M USDFY2022 Net income: 168.7M USDFY2023 Net income: -27.5M USDFY2024 Net income: 151.5M USDFY2025 Net income: 259.6M USD
Revenue Net income10 filed fiscal years, from the annual reports; the table in Filings names each document.
Named tests met
0 of 30 Which tests
The business, and the score behind its five axes

The reading, in brief

Is it cheap

Price to earnings is 15.57x at the close of 2026-10-16 on FY2025 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits between 15.00x and 25.00x.

Today, against the Financial - Capital Markets industry (36 companies), 15.57x sits at the 43rd percentile; the middle half of that group runs from 12.91x to 22.66x.

Is it good

Return on equity was 45.7% in FY2025, in the band labelled "Exceptional, check the leverage" (25.0% and above), on lines anchored on Damodaran's cost-of-capital data, suggesting high returns on shareholders' money, which leverage can also produce.

Today, against the Financial - Capital Markets industry (64 companies), 45.7% sits at the 100th percentile; the middle half of that group runs from -23.4% to 16.4%.

Year by year against peers
Whether Moelis & Company's return on equity stayed above the median of the Financial - Capital Markets industry, year by year. (FY2023 to FY2025, 3 fiscal years of Moelis & Company with a comparable figure)
The direction
Which way Moelis & Company's return on equity has moved, and how steadily. (FY2016 to FY2025, 10 filed years of Moelis & Company)
What could explain it
What in Moelis & Company's filed statements could explain the movements. (1 reading drawn from the statement lines Moelis & Company filed)
What to check next
What to check next on Moelis & Company, and where in its filings. (1 question for Moelis & Company)
In one paragraph
One paragraph on Moelis & Company's returns, cash, balance sheet and price. (2 of sixteen figures read for Moelis & Company)

These are MC’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research MCPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2025 annual report: 10-K, filed Feb 26, 2026, accession 0001193125-26-076747.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

Moelis & Company: returns on capital and margins, each with its source
FigureValue, source and document
Return on invested capital, after tax
Why n/m

Invested capital is equity plus debt less cash. A financial company's debt and cash are operating positions, so returns measured against that base are not comparable to an operating business.

n/m ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Return on equity45.7% ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Return on capital employed, pre-tax
Why n/m

Invested capital is equity plus debt less cash. A financial company's debt and cash are operating positions, so returns measured against that base are not comparable to an operating business.

n/m ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Return on assets14.9% ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Gross margin
Why n/a

Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Operating margin
Why n/a

Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Net margin
Why n/a

Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

Moelis & Company: leverage, liquidity and distress, each with its source
FigureValue, source and document
Debt to equity
Why n/a

The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Current ratio
Why n/a

Our archived statements for this filer carry no current assets line, so we cannot compute this from source and show you where it came from.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Quick ratio
Why n/a

Our archived statements for this filer carry no current assets line, so we cannot compute this from source and show you where it came from.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Interest coverage
Why n/a

No interest expense is filed for this year, so coverage is not computed.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Altman Z-score
Why n/m

Altman's Z-Score was estimated on manufacturers and explicitly excludes financial firms. A financial company scores in the distress zone by construction, so the number would be wrong rather than alarming. Not applicable to financials.

n/m ComputedClose of Oct 16, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Net debt
Why n/a

The FY2025 balance sheet carries no net debt we could read.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Total assets 1.74BTotal liabilities 1.06BShareholders' equity 568.4MOwnsOwes, and equity
Total assets Total liabilities Shareholders’ equity
The balance sheet, line by line

Financial health

What Moelis & Company owned and owed at the end of fiscal 2025, from the balance sheet it filed (10-K, filed Feb 26, 2026, 0001193125-26-076747).

Moelis & Company: balance sheet position
Total assets1.74B FiledFY2025 10-K, filed Feb 26, 2026
Total liabilities1.06B FiledFY2025 10-K, filed Feb 26, 2026
Shareholders' equity568.4M FiledFY2025 10-K, filed Feb 26, 2026
Cash508.6M FiledFY2025 10-K, filed Feb 26, 2026
Total debtn/a FiledFY2025 10-K, filed Feb 26, 2026
Net debtn/a
Current ration/a
Debt to equityn/a
  • Debt to equity: FY2025: The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
  • Current ratio: FY2025: Our archived statements for this filer carry no current assets line, so we cannot compute this from source and show you where it came from.
  • Interest cover: FY2025: No interest expense is filed for this year, so coverage is not computed.

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

Moelis & Company: what the market charges, each with its source
FigureValue, source and document
Price to earnings15.57x ComputedClose of Oct 16, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
P/E on trailing twelve months
Why n/a

A trailing figure needs 4 filed quarters with the dates they were filed on, and we hold 1 for this company. Nothing is drawn rather than a line built from fewer.

n/a ComputedClose of Oct 16, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book7.11x ComputedClose of Oct 16, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Price to sales
Why n/a

Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.

n/a ComputedClose of Oct 16, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Enterprise value to EBIT
Why n/m

Enterprise value adds debt and subtracts cash. For a financial company both are the business itself, so the resulting multiple has no economic meaning.

n/m ComputedClose of Oct 16, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Enterprise value to EBITDA
Why n/m

Enterprise value adds debt and subtracts cash. For a financial company both are the business itself, so the resulting multiple has no economic meaning.

n/m ComputedClose of Oct 16, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Price to earnings over growth
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 16, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Diluted earnings per share
Why n/a

The FY2025 filing carries no diluted earnings per share we could read.

n/a FiledFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Graham number
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747

We publish no fair value or price target of our own. Value MC on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for Moelis & Company today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

Moelis & Company: valuation
Share price54.55 USD
Market capitalisation4.04B USD
Enterprise value to EBITDAn/m
Graham numbern/a
Diluted earnings per sharen/a

Price to earnings on trailing twelve months: A trailing figure needs 4 filed quarters with the dates they were filed on, and we hold 1 for this company. Nothing is drawn rather than a line built from fewer.

Companies like Moelis & Company

  1. Lazard Ltd (LAZ)Market cap 4.03B USD
  2. Piper Sandler Companies (PIPR)Market cap 4.57B USD
  3. Cipher Mining Inc. (CIFR)Market cap 3.73B USD
  4. Figure Technology Solutions, Inc. Class A Common Stock (FIGR)Market cap 5.04B USD
  5. PJT Partners Inc. (PJT)Market cap 3.51B USD

Same industry (Financial - Capital Markets) and size band (Mid, 2B to 10B), nearest in market value. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

Moelis & Company: cash generation and what is paid out, each with its source
FigureValue, source and document
Free cash flow yield
Why n/m

For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.

n/m ComputedClose of Oct 16, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Free cash flow540.0M USD ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Free cash flow margin
Why n/m

For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.

n/m ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Dividend yield4.8% ComputedClose of Oct 16, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Payout ratio
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
FY2016 Free cash flow: 228.7M USDFY2016 Net income: 141.9M USDFY2017 Free cash flow: 227.5M USDFY2017 Net income: 126.5M USDFY2018 Free cash flow: 384.0M USDFY2018 Net income: 208.0M USDFY2019 Free cash flow: 202.8M USDFY2019 Net income: 135.7M USDFY2020 Free cash flow: 388.6M USDFY2020 Net income: 218.4M USDFY2021 Free cash flow: 920.6M USDFY2021 Net income: 423.0M USDFY2022 Free cash flow: 27.0M USDFY2022 Net income: 168.7M USDFY2023 Free cash flow: 141.8M USDFY2023 Net income: -27.5M USDFY2024 Free cash flow: 415.4M USDFY2024 Net income: 151.5M USDFY2025 Free cash flow: 540.0M USDFY2025 Net income: 259.6M USD
Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filing

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

Moelis & Company: the eight ratios, with the fiscal year and filing date behind each.
FigureValueYearAs of
15.57xFY2025Oct 16, 2026
7.11xFY2025Oct 16, 2026
n/mFY2025Oct 16, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
n/mFY2025Oct 16, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
n/mFY2025Feb 26, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
4.8%FY2025Oct 16, 2026
n/aFY2025Feb 26, 2026
n/a The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
n/aFY2025Feb 26, 2026
n/a Our archived statements for this filer carry no current assets line, so we cannot compute this from source and show you where it came from.
n/aFY2025Oct 16, 2026
n/a Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
n/aFY2025Oct 16, 2026
n/a The filed income statement reports no earnings per share.
n/mFY2025Oct 16, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
n/mFY2025Feb 26, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
n/mFY2025Feb 26, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.

The figures are computed from the accounts for fiscal 2025, the newest full year on file. 13 filed fiscal years on record, FY2012 to FY2025, from SEC EDGAR. Prices as of Oct 16, 2026. Ratios recomputed Oct 16, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

10 filed fiscal years, FY2016 to FY2025, read from the annual reports Moelis & Company filed with the SEC. Each year names its filing. Amounts in USD, as filed.

Moelis & Company: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
YearRevenueOperating incomeNet incomeEPS, dilutedFree cash flowOperating marginReturn on equityFiling
FY2025n/a273.9M259.6Mn/a540.0Mn/a45.7%10-K, Feb 26, 20260001193125-26-076747
FY2024n/a172.9M151.5Mn/a415.4Mn/a34.3%10-K, Feb 27, 20250000950170-25-029070
FY2023n/a-40.4M-27.5Mn/a141.8Mn/a-7.8%10-K, Feb 22, 20240000950170-24-018791
FY2022n/a216.1M168.7Mn/a27.0Mn/a38.0%10-K, Feb 23, 20230000950170-23-004120
FY2021n/a495.9M423.0Mn/a920.6Mn/a86.5%10-K, Feb 23, 20220000950170-22-001785
FY2020n/a265.7M218.4Mn/a388.6Mn/a45.5%10-K, Feb 24, 20210001564590-21-008170
FY2019n/a114.5M135.7Mn/a202.8Mn/a30.6%10-K, Feb 27, 20200001564590-20-006910
FY2018n/a226.8M208.0Mn/a384.0Mn/a51.4%10-K, Feb 27, 20190001564590-19-004907
FY2017n/a164.3M126.5Mn/a227.5Mn/a38.9%10-K, Feb 28, 20180001558370-18-001283
FY2016n/a161.1M141.9Mn/a228.7Mn/a67.0%10-K, Feb 28, 20170001558370-17-001153
  • Revenue: Fewer than two filed years carry revenue.
  • Earnings, compound annual growth FY2016 to FY2025: 6.9%
  • Earnings per share: Fewer than two filed years carry earnings per share.
  • Free cash flow, compound annual growth FY2016 to FY2025: 10.0%

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

Moelis & Company: accounting screens and published tests, each with its source
FigureValue, source and document
Beneish M-score
Why n/m

The Beneish M-Score is built on gross margin, receivables and asset quality indices estimated on non-financial firms. Those inputs are not defined here.

n/m ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Piotroski F-score
Why n/m

2 of the nine Piotroski signals are undefined for a capital markets firm: signal 6 (rising current ratio), signal 8 (rising gross margin). We do not publish a partial score under the full score's name.

n/m ComputedFY2025 10-K, filed Feb 26, 2026, 0001193125-26-076747
Named tests met0 of 30 Computed
Beta1.47 ComputedClose of Oct 16, 2026

The named tests

Of 30 tests value investors published: 0 met, 11 not met, 19 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)
Meets
None of the named tests.
Does not
Defensive investor (Benjamin Graham); Deep value; Large cap, low P/E; High F-score, low P/B (Joseph Piotroski); Low beta, profitable; High return on tangibles; Book or below, low debt (Walter Schloss); Tangible book or below; Cheapest quarter on P/E (David Dreman); Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
Not measured
Earnings yield and ROIC (Joel Greenblatt); Three forensic scores; Low PEG, low debt (Peter Lynch); High returns and growth; Gross margin, turnover (Robert Novy-Marx); EV/EBITDA and coverage; High yield, low payout; Dividends and buybacks; ROIC at or above WACC; Near the 52-week low; Z-score and coverage (Edward Altman); Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); High returns, low debt; Owner earnings yield; Low P/S, rising earnings (James O'Shaughnessy); Cash-covered dividend; Cash-flow yield and ROIC; Clean books, high ROIC. A test with a figure we could not read is incomplete, never met and never failed.
Figures we could not read(25)
  • Current Ratio: Our archived statements for this filer carry no current assets line, so we cannot compute this from source and show you where it came from.
  • Debt to Equity: The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
  • Positive Earnings Streak: The latest filed year has no per-share earnings we can read; the test needs 10.
  • Piotroski F-Score: 2 of the nine Piotroski signals are undefined for a capital markets firm: signal 6 (rising current ratio), signal 8 (rising gross margin). We do not publish a partial score under the full score's name.
  • EV/EBIT: Enterprise value adds debt and subtracts cash. For a financial company both are the business itself, so the resulting multiple has no economic meaning.
  • Return on Invested Capital: Invested capital is equity plus debt less cash. A financial company's debt and cash are operating positions, so returns measured against that base are not comparable to an operating business.
  • Altman Z-Score: Altman's Z-Score was estimated on manufacturers and explicitly excludes financial firms. A financial company scores in the distress zone by construction, so the number would be wrong rather than alarming. Not applicable to financials.
  • Beneish M-Score: The Beneish M-Score is built on gross margin, receivables and asset quality indices estimated on non-financial firms. Those inputs are not defined here.
  • PEG Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Eps Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
  • Rev Growth 5Y: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
  • Gross Margin: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
  • Asset Turnover: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
  • EV/EBITDA: Enterprise value adds debt and subtracts cash. For a financial company both are the business itself, so the resulting multiple has no economic meaning.
  • Interest Coverage: No interest expense is filed for this year, so coverage is not computed.
  • Payout Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Free Cash Flow Yield: For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.
  • Share Count Change Yoy: We do not hold this figure for this company, so there is nothing to show.
  • ROIC-WACC Spread: Invested capital is equity plus debt less cash. A financial company's debt and cash are operating positions, so returns measured against that base are not comparable to an operating business.
  • Price To Ncav: Net current asset value needs current assets, which an unclassified balance sheet does not report.
  • Price To Graham: We do not hold this figure for this company, so there is nothing to show.
  • Owner Earnings Yield: For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.
  • Capex To Ocf: For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.
  • P/S Ratio: Our archived income statement for this filer carries no revenue line. A development-stage company files exactly that, with no revenue to report. Either way there is no denominator, and a ratio measured against a missing denominator is not zero, it is nothing.
  • Dividend Coverage Ratio: For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by Javier Sanz Alvarez: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

More on this company

What this cannot tell you

  • 25 figures could not be read on this company, among them Current Ratio, Debt to Equity, Positive Earnings Streak. Each blank in the table above names the rest, with its reason. 19 named tests come back incomplete because of them, which is neither met nor missed.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map
  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.